Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Laquinimod suppress antigen presentation in relapsing-remitting multiple sclerosis: in-vitro high-throughput gene expression study.
Effects of natalizumab treatment on the CSF proteome of multiple sclerosis patients.
Positive year one results from Biogen Idec's Phase 3 advance trial of PLEGRIDY™ (peginterferon beta-1a) presented at AAN meeting
Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved.
Amiloride Clinical Trial In Optic Neuritis (ACTION)
Activities of daily living: evaluation and treatment in persons with multiple sclerosis.
Improved self-efficacy in persons with relapsing remitting multiple sclerosis after an intensive social cognitive wellness program with participation of support partners: a 6-months observational study.
Early bilateral cystoid macular oedema secondary to fingolimod in multiple sclerosis.
Don't stress about it!: Is stress management a disease-modifying therapy for multiple sclerosis?
Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.
Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.
Siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis: Design of the phase 3 EXPAND trial.
Intermittent feeding attenuates clinical course of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Mechanism of action, pharmacokinetics, adverse effects, and therapeutic uses of amiloride hydrochloride, a new potassium-sparing diuretic.
Benign Multiple Sclerosis: Does it exist?
Expression of IL-33 and its epigenetic regulation in Multiple Sclerosis.
Laquinimod in multiple sclerosis.
Normal outcome of pregnancy with ongoing treatment with natalizumab.
Celiac disease and multiple sclerosis in the northwest of Iran.
Receptos provides update on progress of lead product candidate RPC1063
Assessment of the effect of interferon-beta1a therapy on thyroid and salivary gland functions in patients with multiple sclerosis using quantitative salivary gland scintigraphyz.
Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells.
Detecting cortical lesions in multiple sclerosis at 7 T using white matter signal attenuation.
A telerehabilitation program by virtual reality-video games improves balance and postural control in multiple sclerosis patients.
Glatiramer acetate (copaxone) modulates platelet activation and inhibits thrombin-induced calcium influx: possible role of copaxone in targeting platelets during autoimmune neuroinflammation.

Pages